Picture of LigaChem Biosciences logo

141080 LigaChem Biosciences Balance Sheet

0.000.00%
kr flag iconLast trade - 00:00
HealthcareHighly SpeculativeLarge CapNeutral

Annual balance sheet for LigaChem Biosciences, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments170,940158,96593,103483,303470,364
Net Total Accounts Receivable
Net Total Receivables46,52919,81720,88035,54842,091
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets228,951191,619134,619550,262521,442
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment24,43226,49225,42425,31327,711
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets293,233252,530189,502738,383701,815
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities17,01828,60337,072117,18361,092
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities34,45932,93241,281122,385194,201
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Unrealized Gain / Loss
Other Equity
Total Equity258,775219,599148,221615,998507,614
Total Liabilities & Shareholders' Equity293,233252,530189,502738,383701,815
Total Common Shares Outstanding
Total Preferred Shares Outstanding